| PERIOD ENDING | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | 28-Sep-08 | | Total Revenue | 584,485 | 609,022 | 772,054 | 687,042 | | Cost of Revenue | 254,144 | 290,699 | 327,911 | 322,246 | | | Gross Profit | 330,341 | 318,323 | 444,143 | 364,796 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 288,949 | 326,820 | 325,692 | 320,929 | | Non Recurring | (16,363) | 16,363 | 19,158 | 160,430 | | Others | 34,424 | 36,774 | 35,955 | 33,881 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 23,331 | (61,634) | 63,338 | (150,444) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (13,764) | 4,514 |
-
| (8,470) | | Earnings Before Interest And Taxes | 22,404 | (57,120) | 65,136 | (143,650) | | Interest Expense | 21,545 | 18,257 | 12,283 | 11,560 | | Income Before Tax | 859 | (75,377) | 52,853 | (155,210) | | Income Tax Expense | (38,265) | (1,148) | 25,075 | (40,360) | | Minority Interest |
-
|
-
| (130) | (54) | | | | Net Income From Continuing Ops | 39,124 | (74,229) | 27,648 | (114,904) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 8,611 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 39,124 | (74,229) | 27,648 | (106,293) | | Preferred Stock And Other Adjustments | (60) | (239) |
-
|
-
| | | Net Income Applicable To Common Shares | $39,064 | ($74,468) | $27,648 | ($106,293) |
|
2.03% Nasdaq 
Income Statement
